You are here: Home » Current Affairs » Coronavirus » News
Business Standard

AstraZeneca-Oxford's coronavirus vaccine trials resume in Brazil

AstraZeneca paused global trials temporarily last week after an unexplained illness in a participant in Britain.

Topics
AstraZeneca | Coronavirus Vaccine | Brazil

Anthony Boadle | Reuters  |  Brasilia 

Coronavirus, vaccine, covid, drugs, clinical trials
Brazil has the third worst coronavirus outbreak after the United States and India and has become a sought-out testing ground for Covid-19 vaccines under development in Britain, China and Russia

Clinical trials for the being developed by PLC and Oxford University resumed in on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative said.

The Federal University of Sao Paulo, which is running the trials, said in a statement that 4,600 of the planned 5,000 volunteers have been vaccinated in without any of them reporting any serious health issues.

The volunteers have been recruited in Sao Paulo, Rio de Janeiro and Salvador in the northeastern state of Bahia where a hospital is conducting the tests.

paused global trials temporarily last week after an unexplained illness in a participant in Britain.

has the third worst coronavirus outbreak after the United States and India and has become a sought-out testing ground for Covid-19 vaccines under development in Britain, China and Russia.

Phase III clinical trials of Russia's Sputnik V vaccine against Covid-19 will be conducted in the Brazilian states of Bahia and Parana, which has plans to produce the vaccine for Brazil and other Latin American countries.

Phase III clinical trials of a vaccine developed by China's Sinovac Biotech Ltd are under way in the state of Sao Paulo, whose governor said last week it may be available to Brazilians as early as December.

Some 9,000 Brazilian volunteers are participating in the Sinovac vaccine trials, which are being conducted by the Butantan Institute in Sao Paulo city and 11 other locations, including the capital Brasilia.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, September 15 2020. 00:10 IST
RECOMMENDED FOR YOU